GAPDH may therefore participate in the development of AS plaques.[75] Ebrahimi et al[76] proposed that inhibiting GAPDH in individuals with a weakened cellular innate immune response (e.g., in older people) may help treat viral diseases such as COVID-19. The gene discussed is GAPDH; the disease is viral load.